PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$1.76
0.00 (0.00%)
β²
5d:
-3.56%
30d:
-14.15%
90d:
-18.89%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π MIXED SIGNALS: PETS shows conflicting indicators. Wait for confirmation before entering.
π MIXED SIGNALS: PETS shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $1.76, which is considered oversold relative to its 30-day fair value range of $1.85 to $2.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.1) compared to its historical average (159.7). Remarkably, the market is currently pricing in an annual earnings decline of 46.0% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $1.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.15 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $1.71. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.15 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.85 -
$2.03
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.2% below Wall St target ($2.15)
- WARNING: Composite score 52/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.85 -
$2.03
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.71
Resistance Level
$2.05
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.14
Wall Street Target
$2.15
(+22.2%)
Revenue Growth (YoY)
-19.9%
Earnings Growth (YoY)
266.7%
Profit Margin
-17.3%
Valuation Discount vs History
-46.0% cheaper
PE vs Historical
25.1 vs 159.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-46.0%
(market-implied from PE analysis)
1-Year Target
$1.58
(-10%)
2-Year Target
$1.43
(-19%)
3-Year Target
$1.28
(-27%)
3-Yr Target (if PE normalizes)
(PE: 25β160)
$8.15
(+363%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.1 to 159.7
Stabilization Target:
$11.18
(+535.2%)
PE Expansion Potential:
+535.2%
Share & Embed Analysis
Last updated: August 23, 2026 11:27 AM ET
Data refreshes hourly during market hours. Next update: 12:27 PM
Data refreshes hourly during market hours. Next update: 12:27 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$5 | 35 SELL |